These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33527031)

  • 41. Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction.
    Agopian VG; Markovic D; Klintmalm GB; Saracino G; Chapman WC; Vachharajani N; Florman SS; Tabrizian P; Haydel B; Nasralla D; Friend PJ; Boteon YL; Ploeg R; Harlander-Locke MP; Xia V; DiNorcia J; Kaldas FM; Yersiz H; Farmer DG; Busuttil RW
    J Hepatol; 2021 Apr; 74(4):881-892. PubMed ID: 32976864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.
    Xie H; Zhang L; Guo D; Yang Z; Zhu H; Zhou K; Feng X; Wei Q; Xu X; Song P; Wen X; Li J; Liu J; Zheng S
    Transplantation; 2020 Jan; 104(1):79-89. PubMed ID: 31283675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort study.
    Lominchar PL; Orue-Echebarria MI; Martín L; Lisbona CJ; Salcedo MM; Olmedilla L; Sharma H; Asencio JM; López-Baena JÁ
    World J Hepatol; 2019 Sep; 11(9):689-700. PubMed ID: 31598193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation.
    Zhu Z; Tang Y; Huang S; Zhao Q; Schroder PM; Zhang Z; Zhang Y; Sun C; Wang L; Ju W; Wang D; Guo Z; He X
    Clin Transplant; 2018 Dec; 32(12):e13438. PubMed ID: 30383902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors of early liver dysfunction after liver transplantation using grafts from donation after citizen death donors.
    He YB; Sun JS; Wang ZP; Yao G; Bai L; Li T; Zhao JM
    Transpl Immunol; 2022 Apr; 71():101525. PubMed ID: 34990790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation.
    Friedman BH; Wolf JH; Wang L; Putt ME; Shaked A; Christie JD; Hancock WW; Olthoff KM
    Liver Transpl; 2012 Feb; 18(2):166-76. PubMed ID: 22006860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of real-time metabolomics in liver transplantation: Graft evaluation and donor-recipient matching.
    Faitot F; Besch C; Battini S; Ruhland E; Onea M; Addeo P; Woehl-Jaeglé ML; Ellero B; Bachellier P; Namer IJ
    J Hepatol; 2018 Apr; 68(4):699-706. PubMed ID: 29191459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations.
    Rammohan A; Rela M; Kim DS; Soejima Y; Kasahara M; Ikegami T; Spiro M; Aristotle Raptis D; Humar A;
    Clin Transplant; 2022 Oct; 36(10):e14657. PubMed ID: 35344628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A score model for the continuous grading of early allograft dysfunction severity.
    Pareja E; Cortes M; Hervás D; Mir J; Valdivieso A; Castell JV; Lahoz A
    Liver Transpl; 2015 Jan; 21(1):38-46. PubMed ID: 25204890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of lactate clearance for the development of early allograft dysfunction and short-term prognosis in deceased donor liver transplantation.
    Kim DG; Lee JY; Jung YB; Song SH; Lee JG; Han DH; Joo DJ; Ju MK; Choi GH; Choi JS; Kim MS; Kim SI
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 29032588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic profiles and predictors of early allograft dysfunction after human liver transplantation.
    Kurian SM; Fouraschen SM; Langfelder P; Horvath S; Shaked A; Salomon DR; Olthoff KM
    Am J Transplant; 2015 Jun; 15(6):1605-14. PubMed ID: 25828101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
    Satapathy SK; Gonzalez HC; Vanatta J; Dyer A; Angel W; Nouer SS; Kocak M; Kedia SK; Jiang Y; Clark I; Yadak N; Nezakagtoo N; Helmick R; Horton P; Campos L; Agbim U; Maliakkal B; Maluf D; Nair S; Halford HH; Eason JD
    PLoS One; 2020; 15(5):e0232006. PubMed ID: 32407331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.
    Ohara S; Macdonough E; Egbert L; Brooks A; Lizaola-Mayo B; Mathur AK; Aqel B; Reddy KS; Jadlowiec CC
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting Early Graft Dysfunction and Mortality After Liver Transplant Using the De Ritis Ratio.
    Shin EM; Westhaver L; Nersesian S; Boudreau JE; Gala-Lopez BL
    Transplant Proc; 2023 Apr; 55(3):586-596. PubMed ID: 36973148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarkers and predictive models of early allograft dysfunction in liver transplantation - A systematic review of the literature, meta-analysis, and expert panel recommendations.
    Liu J; Martins PN; Bhat M; Pang L; Yeung OWH; Ng KTP; Spiro M; Raptis DA; Man K; Mas VR;
    Clin Transplant; 2022 Oct; 36(10):e14635. PubMed ID: 35291044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunction.
    Xu J; Casas-Ferreira AM; Ma Y; Sen A; Kim M; Proitsi P; Shkodra M; Tena M; Srinivasan P; Heaton N; Jassem W; Legido-Quigley C
    Sci Rep; 2015 Dec; 5():17737. PubMed ID: 26635289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.